Adult Asthma Remission

*ACQ, Asthma Control Questionnaire; ACT, Asthma Control Test; AirQ, Asthma Impairment and Risk Questionnaire; FEV1, forced expiratory volume in 1 second; ICS, inhaled corticosteroids; OCS, oral corticosteroids.

*ICS, inhaled corticosteroids; LABA, long-acting beta agonist; SABA, short-acting beta agonist; SCS, systemic corticosteroids.

*Adapted from GINA and ERS/ATS. †Severe exacerbation was defined as worsening asthma requiring at least 3 days of treatment with systemic corticosteroids, or a hospitalization due to asthma. ATS, American Thoracic Society; BD, bronchodilator; ERS, European Respiratory Society; FEV1, forced expiratory volume in 1 second; GINA, Global Initiative for Asthma.

*Adapted from GINA and ERS/ATS. †P<0.001.20
AE, adverse event; ATS, American Thoracic Society; ERS, European Respiratory Society; GI, gastrointestinal; GINA, Global Initiative for Asthma; OCS, oral corticosteroids.

*Adapted from GINA and ERS/ATS. †n=1865; Cox proportional hazard model analysis adjusted for age at index date, smoking status, body mass index, gender, rhinitis, chronic sinusitis, nasal polyps, atopic dermatitis, diabetes, anaphylaxis, ischemic heart disease, heart failure, food allergy, anxiety, depression, and psoriasis.8 ‡n=1075; relative risk of death from asthma during 25 years of follow-up.9 ATS, American Thoracic Society; BD, bronchodilator; CI, confidence interval; ERS, European Respiratory Society; FEV1, forced expiratory volume in 1 second; FEV1pp, FEV1 percent predicted; GINA, Global Initiative for Asthma; HR, hazard ratio.

*Adapted from GINA and ERS/ATS.
ACQ, Asthma Control Questionnaire; ACT, Asthma Control Test; ATS, American Thoracic Society; BD, bronchodilator; ERS, European Respiratory Society; FEV1, forced expiratory flow in 1 second; GINA, Global Initiative for Asthma.

1. Lommatzsch M, et al. S2k-Leitlinie zur fachärztlichen Diagnostik     und Therapie von Asthma 2023 [S2k guidelines for specialist     diagnostics and treatment of asthma 2023]. Published by the     German Respiratory Society (DGP) 6 March 2023. Accessed
11 November 2023. https://register.awmf.org/assets/ guidelines/020-009l_S2k_Fachaerztliche-Diagnostik-Therapie-von- Asthma_2023-03.pdf
2. GEMA 5.3: Guía Española para el manejo del asma [GEMA 5.3:     Spanish asthma management guidelines]. Accessed 11 November     2023. https://www.separ.es/node/1827
3. Canonica GW, et al. J Allergy Clin Immunol Pract. 2023;11(12): 3629-3637.
4. Japan Asthma Society (JAS). Practical Guidelines for Asthma Management (PGAM). Updated July 2023. Accessed 11 November,     2023. https://jasweb.or.jp/guideline.html
5. Blaiss M, et al. Ann Allergy Asthma Immunol. 2023;131(6):782-785.
6. Menzies-Gow A, et al. J Allergy Clin Immunol. 2020;145(3):757-765.
7. Thomas D, et al. Eur Respir J. 2022;60(5):2102583.
8. Bieber T. Nat Rev Drug Discov. 2023;22(8):662-680.
9. Busse WW, et al. Eur Respir Rev. 2022;31(163):210183.
10. Lommatzsch M, et al. Lancet. 2022;399(10335):1664-1668.
11. Barach AL. J Am Med Assoc. 1951;147(8):730-737.
12. Sullivan TJ. Pediatr Clin North Am. 1992;39(6):1363-1382.
13. Upham JW, James AL. Pharmacol Ther. 2011;130(1):38-45.
14. Crompton G. Prim Care Respir J. 2006;15(6):326-331.
15. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. Updated May 2023. Accessed 2 May 2023. https://ginasthma.org/ gina-reports/.
16. Chung KF, et al. Eur Respir J. 2014;43(2):343-373.
17. Matsunaga K, et al. J Allergy Clin Immunol Pract. 2015;3(5):759-764.
18. Sullivan PW, et al. J Allergy Clin Immunol. 2018;141(1):110-116.e7.
19. Bleecker ER, et al. Am J Respir Crit Care Med. 2020;201(3):276-293.
20. Waljee AK, et al. BMJ. 2017;357:j1415
21. Khan AH, et al. J Asthma Allergy. 2022;15:1639-1644.
22. Ali Z, et al. Chest. 2013;143(6):1649-1655.
23. Kawamatawong T, et al. Asian Pac J Allergy Immunol. 2022;40(1):1-21.
24. Barnes PJ, et al. Allergy. 2014;69(9):1119-1140.
25. Juniper EF, et al. Respir Med. 2006;100(4):616-621.
26. Schatz M, et al. J Allergy Clin Immunol. 2006;117(3):549-556.
27. Schatz M, et al. J Allergy Clin Immunol. 2009;124(4):719-23.e1.